ArticleJournal of gastroenterology2018

Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials.

Yuya Seko et al.PubMed ↗Publisher ↗

No numbers read from the abstract.